A 4′‐Thioribouridine Modification Mimics 2′‐ O ‐Methoxyethyl in ASO‐Like 20‐Mers Targeting PTEN Knockdown
ChemBioChem · 2026
DOI: 10.1002/cbic.70533 ↗At a glance
Journal article in ChemBioChem, 2026. Written by Joanna E Parkes and 10 co-authors. Institution: MRC Nucleic Acid Therapy Accelerator (NATA), Research Complex at Harwell (RCaH), Oxford, UK. Major MEDLINE topics: PTEN Phosphohydrolase, Oligonucleotides, Antisense, Thiouridine. 25 references. The full text is freely available (open access, CC BY 4.0). Funded by: Medical Research Council, UK Medical Research Council.
Abstract (original language)
Gapmer antisense oligonucleotides (ASOs) represent a clinically validated therapeutic platform, with a 2′‐ O ‐methoxyethyl modification commonplace within the flanking regions. An alternative sugar modification, incorporation of 4′‐thioribose, has demonstrated enhanced nuclease resistance in siRNAs and aptamers, but incorporation of this motif into gapmer architectures remains underexplored. Herein, we report the synthesis of a 4′‐thiouridine phosphoramidite building block and its incorporation into gapmer ASOs targeting PTEN . Evaluation of sequences containing 4′‐thiouridine in the flanking regions (compared with 2′‐ O ‐methoxyethyl) and varying phosphorothioate linkage composition demonstrates that the modified gapmers maintain equivalent knockdown efficacy under transfection and gymnotic delivery. These findings indicate 4′‐thioribose as an alternative sugar modification for wider exploration within gapmer ASOs.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- MRC Nucleic Acid Therapy Accelerator (NATA), Research Complex at Harwell (RCaH), Oxford, UK.
- Manchester Institute of Biotechnology & Department of Chemistry, University of Manchester, Manchester, UK.
ORCID profiles: Joanna E Parkes, Sritama Bose, Sarah L Lovelock, Peter L Oliver, Gavin J Miller
Funding
- Medical Research Council
- UK Medical Research Council
Cite
APA
Parkes, J. E., Benckendorff, C. M. M., Malinowska, A. L., Roberts, J., Huynh, H. L., Bose, S., Cochard, L. M., Cheallaigh, A. N., Lovelock, S. L., Oliver, P. L., & Miller, G. J. (2026). A 4′‐Thioribouridine Modification Mimics 2′‐ O ‐Methoxyethyl in ASO‐Like 20‐Mers Targeting PTEN Knockdown. ChemBioChem. https://doi.org/10.1002/cbic.70533
Vancouver
Parkes JE, Benckendorff CMM, Malinowska AL, Roberts J, Huynh HL, Bose S, et al. A 4′‐Thioribouridine Modification Mimics 2′‐ O ‐Methoxyethyl in ASO‐Like 20‐Mers Targeting PTEN Knockdown. ChemBioChem. 2026. doi:10.1002/cbic.70533
BibTeX
@article{Parkes2026,
author = {Parkes, Joanna E and Benckendorff, Caecilie M M and Malinowska, Anna L and Roberts, Jacob and Huynh, Harley L and Bose, Sritama and Cochard, Loïc M and Cheallaigh, Aisling Ní and Lovelock, Sarah L and Oliver, Peter L and Miller, Gavin J},
title = {A 4′‐Thioribouridine Modification Mimics 2′‐ O ‐Methoxyethyl in ASO‐Like 20‐Mers Targeting PTEN Knockdown},
journal = {ChemBioChem},
year = {2026},
doi = {10.1002/cbic.70533}
}
EUVIMED